Big News Roundup: INDIVA Granted Import Permit for Cannabis Strains; Green Growth Brands to Acquire Xanthic Biopharma; Maricann License Approved by Maltese Government

In case you missed it, here is this week’s cannabis big news roundup.

5 Top Weekly NASDAQ Biotech Stocks: MiMedx Group Leads

MiMedx Group, Avid Bioservices, Lifevantage, EyePoint Pharmaceuticals, and BioLife Solutions were last week's top gainers on the NASDAQ Biotechnology Index.

5 Top Weekly NASDAQ Biotech Stocks: Arbutus on Top

Adamis Pharmaceutical, Juniper Pharmaceuticals, Anavex Life Sciences, Arbutus BioPharma and Soleno Therapeutics were last week's top gainers on the NASDAQ...

5 Top Pharma Stocks on the NASDAQ Year-to-Date

About half way through 2018 finishing the second quarter, the INN takes a look at the 5 top pharma stocks...

4 Top Biotech Stocks on the TSX Year-to-Date

Which biotech stocks on the TSX have performed the best year-to-date? These four companies have risen to the top of...

4 Top Pharma Stocks on the TSX Year-to-Date

As investors look ahead to the remainder of 2018, we've put together a list of the top-gaining pharmaceutical stocks on...

5 Top Weekly NASDAQ Biotech Stocks: Avid Bioservices on Top

Avid Bioservices, Arbutus Biopharma, Catalyst, ArQule and CTI BioPharma were last week's top gainers on the NASDAQ Biotechnology Index.

5 Top NASDAQ Genetic Stocks Year-to-Date

In the final days of Q2 2018, we've profiled the five top NASDAQ genetic stocks year-to-date. Here's a look at...

CSE Marijuana Stocks

INN offers investors a growing list of all marijuana stocks listed on the CSE.

Inovio Doses First Patient in Phase 1/2 Study for Glioblastoma

Roughly 50 newly diagnosed GBM patients will participate in the open-label trial. The study began on May 31, 2018 is...